ClearPoint Neuro (CLPT) EBT (2011 - 2026)
ClearPoint Neuro (CLPT) reported EBT of -$9.5 million for Q1 2026, down 58.85% on a YoY basis from -$23.2 million in Q1 2025, and down 22.64% sequentially from -$7.8 million in Q4 2025.
ClearPoint Neuro (CLPT) EBT (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of EBT data on file, last reported at -$9.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 58.85% year-over-year to -$9.5 million; the trailing twelve-month figure through Mar 2026 stood at -$29.0 million (down 39.67% YoY), and the FY2025 full-year result was -$25.5 million, down 34.83% from the prior year.
- EBT eased to -$9.5 million in Q1 2026, from -$7.8 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$4.1 million in Q1 2024 to a low of -$14.7 million in Q2 2022.
- A 5-year average of -$7.6 million and a median of -$6.0 million in 2025 frame the typical range for EBT.
- Across the five-year window, EBT jumped 62.61% in 2024 and plunged 58.85% in 2026, its largest moves.
- Tracing CLPT's EBT over 5 years: stood at -$4.6 million in 2022, then retreated by 5.47% to -$4.9 million in 2023, then declined by 10.68% to -$5.4 million in 2024, then tumbled by 43.63% to -$7.8 million in 2025, then fell by 22.64% to -$9.5 million in 2026.
- Business Quant data shows CLPT's EBT at -$9.5 million in Q1 2026, -$7.8 million in Q4 2025, and -$5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -9.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.54 Mn |
| Dec 31, 2025 | -7.78 Mn |
| Sep 30, 2025 | -5.88 Mn |
| Jun 30, 2025 | -5.81 Mn |
| Mar 31, 2025 | -6.01 Mn |
| Dec 31, 2024 | -5.42 Mn |
| Sep 30, 2024 | -4.96 Mn |
| Jun 30, 2024 | -4.39 Mn |
| Mar 31, 2024 | -4.13 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -6.76 Mn |
| Jun 30, 2023 | -11.23 Mn |
| Mar 31, 2023 | -11.05 Mn |
| Dec 31, 2022 | -4.64 Mn |
| Sep 30, 2022 | -11.05 Mn |
| Jun 30, 2022 | -14.68 Mn |
| Mar 31, 2022 | -11.36 Mn |
| Dec 31, 2021 | -4.08 Mn |
| Sep 30, 2021 | -19.13 Mn |
| Jun 30, 2021 | -18.32 Mn |